A clinical-stage biotechnology company focused on developing regenerative cell therapies derived from stem cells to treat degenerative diseases. Its pipeline includes programs targeting conditions such as geographic atrophy and spinal cord injury, areas with significant unmet medical need. Investors...
No congressional trades have been disclosed for Lineage Cell Therapeutics, Inc. (LCTX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.